Academic Journal

Drug deprescribing policy and incentives in France

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Drug deprescribing policy and incentives in France
Συγγραφείς: Megerlin, Francis, Bouvenot, Gilles, Queneau, Patrice
Συνεισφορές: MEGERLIN, Francis
Πηγή: Annales Pharmaceutiques Françaises. 83:933-940
Στοιχεία εκδότη: Elsevier BV, 2025.
Έτος έκδοσης: 2025
Θεματικοί όροι: [SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciences, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Deprescribing, [SHS.DROIT] Humanities and Social Sciences/Law, Physicians, Polypharmacy, Financial incentives, France, Pharmacists, [SHS.ECO] Humanities and Social Sciences/Economics and Finance
Περιγραφή: Deprescribing inappropriate drug treatments is a public health issue particularly in countries with a high level of polymedication (polypharmacy). Despite the introduction of the term 'deprescribing' in France in 2002 and the clinical practice guidelines, progress in the outpatient sector has been limited. Our article describes the financial incentives adopted by national agreements between the Assurance Maladie (France's compulsory health insurer scheme) and unions of independent practitioners: pharmacists are encouraged to draw up and share medication reviews (since 2018, target population extended in 2022). As the outcomes have been modest, doctors have then been since 2024 also incentivised to offer medical consultations explicitly dedicated to deprescribing, and to prescribe medication reviews to be drawn up by pharmacists. This article describes the new legal framework for outpatient and inpatient services. It calls for the results expected from 2025 onwards to be measured and studied in national health databases, thanks to the coding associated with these new services.
Τύπος εγγράφου: Article
Γλώσσα: English
ISSN: 0003-4509
DOI: 10.1016/j.pharma.2025.04.003
Σύνδεσμος πρόσβασης: https://pubmed.ncbi.nlm.nih.gov/40274014
Rights: Elsevier TDM
Αριθμός Καταχώρησης: edsair.doi.dedup.....589e3d2bb10a1aa6a660c59b70a721e7
Βάση Δεδομένων: OpenAIRE
Περιγραφή
ISSN:00034509
DOI:10.1016/j.pharma.2025.04.003